Global Biologic Therapeutics Market Growth (Status and Outlook) 2023-2029

Global Biologic Therapeutics Market Growth (Status and Outlook) 2023-2029

Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.

LPI (LP Information)' newest research report, the “Biologic Therapeutics Industry Forecast” looks at past sales and reviews total world Biologic Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologic Therapeutics sales for 2023 through 2029. With Biologic Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Biologic Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologic Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologic Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic Therapeutics.

The global Biologic Therapeutics market size is projected to grow from US$ 432730 million in 2022 to US$ 842720 million in 2029; it is expected to grow at a CAGR of 10.0% from 2023 to 2029.

First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Therapeutics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products

Segmentation by application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma

Please note: The report will take approximately 2 business days to prepare and deliver.